1. INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. RESEARCH METHODOLOGY
1.2.1 SECONDARY RESEARCH
1.2.2 DATA ANALYSIS FRAMEWORK
1.2.3 MARKET SIZE ESTIMATION
1.2.4 FORECASTING
1.2.5 PRIMARY RESEARCH AND DATA VALIDATION
2. MARKET SNAPSHOT, 2019-2030 MILLION USD
2.1. MARKET SNAPSHOT
3. PORTER’S FIVE FORCE MODEL ANALYSIS
4. MARKET DYNAMICS
4.1. GROWTH DRIVERS
4.1.1 DRIVER 1
4.1.2 DRIVER 2
4.1.3 DRIVER 3
4.1.4 DRIVER 4
4.2. CHALLENGES
4.2.1 CHALLENGE 1
4.2.2 CHALLENGE 2
4.3. OPPORTUNITIES
4.3.1 OPPORTUNITY 1
4.3.2 OPPORTUNITY 2
5. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENTS
5.1. OVERVIEW
5.2. SENSORS
5.2.1 SENSORS MARKET, BY REGION
5.2.1.1 NORTH AMERICA SENSORS MARKET, BY COUNTRY
5.2.1.2 EUROPE SENSORS MARKET, BY COUNTRY
5.2.1.3 ASIA-PACIFIC SENSORS MARKET, BY COUNTRY
5.2.1.4 REST OF WORLD SENSORS MARKET, BY COUNTRY
5.3. TRANSMITTERS & RECEIVERS
5.3.1 TRANSMITTERS & RECEIVERS MARKET, BY REGION
5.3.1.1 NORTH AMERICA TRANSMITTERS & RECEIVERS MARKET, BY COUNTRY
5.3.1.2 EUROPE TRANSMITTERS & RECEIVERS MARKET, BY COUNTRY
5.3.1.3 ASIA-PACIFIC TRANSMITTERS & RECEIVERS MARKET, BY COUNTRY
5.3.1.4 REST OF WORLD TRANSMITTERS & RECEIVERS MARKET, BY COUNTRY
5.4. INTEGRATED INSULIN PUMPS
5.4.1 INTEGRATED INSULIN PUMPS MARKET, BY REGION
5.4.1.1 NORTH AMERICA INTEGRATED INSULIN PUMPS MARKET, BY COUNTRY
5.4.1.2 EUROPE INTEGRATED INSULIN PUMPS MARKET, BY COUNTRY
5.4.1.3 ASIA-PACIFIC INTEGRATED INSULIN PUMPS MARKET, BY COUNTRY
5.4.1.4 REST OF WORLD INTEGRATED INSULIN PUMPS MARKET, BY COUNTRY
6. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS
6.1. OVERVIEW
6.2. ADULT POPULATION (>14 YEARS)
6.2.1 ADULT POPULATION (>14 YEARS) MARKET, BY REGION
6.2.1.1 NORTH AMERICA ADULT POPULATION (>14 YEARS) MARKET, BY COUNTRY
6.2.1.2 EUROPE ADULT POPULATION (>14 YEARS) MARKET, BY COUNTRY
6.2.1.3 ASIA-PACIFIC ADULT POPULATION (>14 YEARS) MARKET, BY COUNTRY
6.2.1.4 REST OF WORLD ADULT POPULATION (>14 YEARS) MARKET, BY COUNTRY
6.3. CHILDREN POPULATION (≤14 YEARS)
6.3.1 CHILDREN POPULATION (≤14 YEARS) MARKET, BY REGION
6.3.1.1 NORTH AMERICA CHILDREN POPULATION (≤14 YEARS) MARKET, BY COUNTRY
6.3.1.2 EUROPE CHILDREN POPULATION (≤14 YEARS) MARKET, BY COUNTRY
6.3.1.3 ASIA-PACIFIC CHILDREN POPULATION (≤14 YEARS) MARKET, BY COUNTRY
6.3.1.4 REST OF WORLD CHILDREN POPULATION (≤14 YEARS) MARKET, BY COUNTRY
7. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
7.1. OVERVIEW
7.2. DIAGNOSTIC CENTERS/CLINICS
7.2.1 DIAGNOSTIC CENTERS/CLINICS MARKET, BY REGION
7.2.1.1 NORTH AMERICA DIAGNOSTIC CENTERS/CLINICS MARKET, BY COUNTRY
7.2.1.2 EUROPE DIAGNOSTIC CENTERS/CLINICS MARKET, BY COUNTRY
7.2.1.3 ASIA-PACIFIC DIAGNOSTIC CENTERS/CLINICS MARKET, BY COUNTRY
7.2.1.4 REST OF WORLD DIAGNOSTIC CENTERS/CLINICS MARKET, BY COUNTRY
7.3. ICUS
7.3.1 ICUS MARKET, BY REGION
7.3.1.1 NORTH AMERICA ICUS MARKET, BY COUNTRY
7.3.1.2 EUROPE ICUS MARKET, BY COUNTRY
7.3.1.3 ASIA-PACIFIC ICUS MARKET, BY COUNTRY
7.3.1.4 REST OF WORLD ICUS MARKET, BY COUNTRY
7.4. HOME HEALTHCARE
7.4.1 HOME HEALTHCARE MARKET, BY REGION
7.4.1.1 NORTH AMERICA HOME HEALTHCARE MARKET, BY COUNTRY
7.4.1.2 EUROPE HOME HEALTHCARE MARKET, BY COUNTRY
7.4.1.3 ASIA-PACIFIC HOME HEALTHCARE MARKET, BY COUNTRY
7.4.1.4 REST OF WORLD HOME HEALTHCARE MARKET, BY COUNTRY
8. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION
8.1. OVERVIEW
8.2. NORTH AMERICA
8.2.1 NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT
8.2.2 NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS
8.2.3 NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
8.2.4 NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS , MARKET BY COUNTRY
8.2.4.1 U.S.
8.2.4.1.1 U.S. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENTS
8.2.4.1.2 U.S. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS
8.2.4.1.3 U.S. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
8.2.4.2 CANADA
8.2.4.2.1 CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENTS
8.2.4.2.2 CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS
8.2.4.2.3 CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
8.2.4.3 MEXICO
8.2.4.3.1 MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENTS
8.2.4.3.2 MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS
8.2.4.3.3 MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
8.3. EUROPE
8.3.1 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT
8.3.2 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS
8.3.3 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
8.3.4 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS , MARKET BY COUNTRY
8.3.4.1 UK
8.3.4.1.1 UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENTS
8.3.4.1.2 UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS
8.3.4.1.3 UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
8.3.4.2 GERMANY
8.3.4.2.1 GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENTS
8.3.4.2.2 GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS
8.3.4.2.3 GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
8.3.4.3 FRANCE
8.3.4.3.1 FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENTS
8.3.4.3.2 FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS
8.3.4.3.3 FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
8.3.4.4 ITALY
8.3.4.4.1 ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENTS
8.3.4.4.2 ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS
8.3.4.4.3 ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
8.3.4.5 SPAIN
8.3.4.5.1 SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENTS
8.3.4.5.2 SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS
8.3.4.5.3 SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
8.3.4.6 NETHERLANDS
8.3.4.6.1 NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENTS
8.3.4.6.2 NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS
8.3.4.6.3 NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
8.3.4.7 SWEDEN
8.3.4.7.1 SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENTS
8.3.4.7.2 SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS
8.3.4.7.3 SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
8.3.4.8 DENMARK
8.3.4.8.1 DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENTS
8.3.4.8.2 DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS
8.3.4.8.3 DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
8.3.4.9 FINLAND
8.3.4.9.1 FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENTS
8.3.4.9.2 FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS
8.3.4.9.3 FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
8.3.4.10 REST OF EUROPE
8.3.4.10.1 REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENTS
8.3.4.10.2 REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS
8.3.4.10.3 REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
8.4. ASIA-PACIFIC
8.4.1 ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT
8.4.2 ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS
8.4.3 ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
8.4.4 ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS , MARKET BY COUNTRY
8.4.4.1 INDIA
8.4.4.1.1 INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENTS
8.4.4.1.2 INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS
8.4.4.1.3 INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
8.4.4.2 CHINA
8.4.4.2.1 CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENTS
8.4.4.2.2 CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS
8.4.4.2.3 CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
8.4.4.3 JAPAN
8.4.4.3.1 JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENTS
8.4.4.3.2 JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS
8.4.4.3.3 JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
8.4.4.4 AUSTRALIA
8.4.4.4.1 AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENTS
8.4.4.4.2 AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS
8.4.4.4.3 AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
8.4.4.5 SOUTH KOREA
8.4.4.5.1 SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENTS
8.4.4.5.2 SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS
8.4.4.5.3 SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
8.4.4.6 REST OF ASIA-PACIFIC
8.4.4.6.1 REST OF ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENTS
8.4.4.6.2 REST OF ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS
8.4.4.6.3 REST OF ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
8.5. REST OF WORLD
8.5.1 REST OF WORLD CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT
8.5.2 REST OF WORLD CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS
8.5.3 REST OF WORLD CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
8.5.4 REST OF WORLD CONTINUOUS GLUCOSE MONITORING SYSTEMS , MARKET BY COUNTRY
8.5.4.1 BRAZIL
8.5.4.1.1 BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENTS
8.5.4.1.2 BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS
8.5.4.1.3 BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
8.5.4.2 SAUDI ARABIA
8.5.4.2.1 SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENTS
8.5.4.2.2 SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS
8.5.4.2.3 SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
8.5.4.3 SOUTH AFRICA
8.5.4.3.1 SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENTS
8.5.4.3.2 SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS
8.5.4.3.3 SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
8.5.4.4 VENEZUELA
8.5.4.4.1 VENEZUELA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENTS
8.5.4.4.2 VENEZUELA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS
8.5.4.4.3 VENEZUELA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
8.5.4.5 ARGENTINA
8.5.4.5.1 ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENTS
8.5.4.5.2 ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS
8.5.4.5.3 ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
8.5.4.6 REMAINING COUNTRIES
8.5.4.6.1 REMAINING COUNTRIES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENTS
8.5.4.6.2 REMAINING COUNTRIES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS
8.5.4.6.3 REMAINING COUNTRIES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
9. COMPANY PROFILES
9.1. ABBOTT LABORATORIES
9.1.1 COMPANY OVERVIEW
9.1.2 COMPANY SNAPSHOT
9.1.3 OPERATING BUSINESS SEGMENTS
9.1.4 PRODUCT PORTFOLIO
9.1.5 BUSINESS PERFORMANCE
9.1.6 KEY STRATEGIC MOVES AND DEVELOPMENT
9.2. MENARINI DIAGNOSTICS S.R.L.
9.2.1 COMPANY OVERVIEW
9.2.2 COMPANY SNAPSHOT
9.2.3 OPERATING BUSINESS SEGMENTS
9.2.4 PRODUCT PORTFOLIO
9.2.5 BUSINESS PERFORMANCE
9.2.6 KEY STRATEGIC MOVES AND DEVELOPMENT
9.3. DEXCOM, INC.
9.3.1 COMPANY OVERVIEW
9.3.2 COMPANY SNAPSHOT
9.3.3 OPERATING BUSINESS SEGMENTS
9.3.4 PRODUCT PORTFOLIO
9.3.5 BUSINESS PERFORMANCE
9.3.6 KEY STRATEGIC MOVES AND DEVELOPMENT
9.4. ECHO THERAPEUTICS, INC.
9.4.1 COMPANY OVERVIEW
9.4.2 COMPANY SNAPSHOT
9.4.3 OPERATING BUSINESS SEGMENTS
9.4.4 PRODUCT PORTFOLIO
9.4.5 BUSINESS PERFORMANCE
9.4.6 KEY STRATEGIC MOVES AND DEVELOPMENT
9.5. HOFFMANN-LA ROCHE LTD.
9.5.1 COMPANY OVERVIEW
9.5.2 COMPANY SNAPSHOT
9.5.3 OPERATING BUSINESS SEGMENTS
9.5.4 PRODUCT PORTFOLIO
9.5.5 BUSINESS PERFORMANCE
9.5.6 KEY STRATEGIC MOVES AND DEVELOPMENT
9.6. GLYSENS INCORPORATED
9.6.1 COMPANY OVERVIEW
9.6.2 COMPANY SNAPSHOT
9.6.3 OPERATING BUSINESS SEGMENTS
9.6.4 PRODUCT PORTFOLIO
9.6.5 BUSINESS PERFORMANCE
9.6.6 KEY STRATEGIC MOVES AND DEVELOPMENT
9.7. INSULET CORPORATION
9.7.1 COMPANY OVERVIEW
9.7.2 COMPANY SNAPSHOT
9.7.3 OPERATING BUSINESS SEGMENTS
9.7.4 PRODUCT PORTFOLIO
9.7.5 BUSINESS PERFORMANCE
9.7.6 KEY STRATEGIC MOVES AND DEVELOPMENT
9.8. JOHNSON & JOHNSON
9.8.1 COMPANY OVERVIEW
9.8.2 COMPANY SNAPSHOT
9.8.3 OPERATING BUSINESS SEGMENTS
9.8.4 PRODUCT PORTFOLIO
9.8.5 BUSINESS PERFORMANCE
9.8.6 KEY STRATEGIC MOVES AND DEVELOPMENT
9.9. MEDRONIC PLC
9.9.1 COMPANY OVERVIEW
9.9.2 COMPANY SNAPSHOT
9.9.3 OPERATING BUSINESS SEGMENTS
9.9.4 PRODUCT PORTFOLIO
9.9.5 BUSINESS PERFORMANCE
9.9.6 KEY STRATEGIC MOVES AND DEVELOPMENT
9.10. SENSEONICS HOLDINGS, INC.
9.10.1 COMPANY OVERVIEW
9.10.2 COMPANY SNAPSHOT
9.10.3 OPERATING BUSINESS SEGMENTS
9.10.4 PRODUCT PORTFOLIO
9.10.5 BUSINESS PERFORMANCE
9.10.6 KEY STRATEGIC MOVES AND DEVELOPMENT
LIST OF TABLES
TABLE 1. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENTS, 2019-2030, MILLION USD
TABLE 2. SENSORS MARKET VALUE, BY REGION, 2019-2030, MILLION USD
TABLE 3. NORTH AMERICA SENSORS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
TABLE 4. EUROPE SENSORS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
TABLE 5. ASIA-PACIFIC SENSORS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
TABLE 6. REST OF WORLD SENSORS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
TABLE 7. TRANSMITTERS & RECEIVERS MARKET VALUE, BY REGION, 2019-2030, MILLION USD
TABLE 8. NORTH AMERICA TRANSMITTERS & RECEIVERS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
TABLE 9. EUROPE TRANSMITTERS & RECEIVERS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
TABLE 10. ASIA-PACIFIC TRANSMITTERS & RECEIVERS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
TABLE 11. REST OF WORLD TRANSMITTERS & RECEIVERS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
TABLE 12. INTEGRATED INSULIN PUMPS MARKET VALUE, BY REGION, 2019-2030, MILLION USD
TABLE 13. NORTH AMERICA INTEGRATED INSULIN PUMPS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
TABLE 14. EUROPE INTEGRATED INSULIN PUMPS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
TABLE 15. ASIA-PACIFIC INTEGRATED INSULIN PUMPS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
TABLE 16. REST OF WORLD INTEGRATED INSULIN PUMPS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
TABLE 17. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
TABLE 18. ADULT POPULATION (>14 YEARS) MARKET VALUE, BY REGION, 2019-2030, MILLION USD
TABLE 19. NORTH AMERICA ADULT POPULATION (>14 YEARS) MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
TABLE 20. EUROPE ADULT POPULATION (>14 YEARS) MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
TABLE 21. ASIA-PACIFIC ADULT POPULATION (>14 YEARS) MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
TABLE 22. REST OF WORLD ADULT POPULATION (>14 YEARS) MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
TABLE 23. CHILDREN POPULATION (≤14 YEARS) MARKET VALUE, BY REGION, 2019-2030, MILLION USD
TABLE 24. NORTH AMERICA CHILDREN POPULATION (≤14 YEARS) MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
TABLE 25. EUROPE CHILDREN POPULATION (≤14 YEARS) MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
TABLE 26. ASIA-PACIFIC CHILDREN POPULATION (≤14 YEARS) MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
TABLE 27. REST OF WORLD CHILDREN POPULATION (≤14 YEARS) MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
TABLE 28. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
TABLE 29. DIAGNOSTIC CENTERS/CLINICS MARKET VALUE, BY REGION, 2019-2030, MILLION USD
TABLE 30. NORTH AMERICA DIAGNOSTIC CENTERS/CLINICS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
TABLE 31. EUROPE DIAGNOSTIC CENTERS/CLINICS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
TABLE 32. ASIA-PACIFIC DIAGNOSTIC CENTERS/CLINICS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
TABLE 33. REST OF WORLD DIAGNOSTIC CENTERS/CLINICS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
TABLE 34. ICUS MARKET VALUE, BY REGION, 2019-2030, MILLION USD
TABLE 35. NORTH AMERICA ICUS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
TABLE 36. EUROPE ICUS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
TABLE 37. ASIA-PACIFIC ICUS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
TABLE 38. REST OF WORLD ICUS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
TABLE 39. HOME HEALTHCARE MARKET VALUE, BY REGION, 2019-2030, MILLION USD
TABLE 40. NORTH AMERICA HOME HEALTHCARE MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
TABLE 41. EUROPE HOME HEALTHCARE MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
TABLE 42. ASIA-PACIFIC HOME HEALTHCARE MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
TABLE 43. REST OF WORLD HOME HEALTHCARE MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
TABLE 44. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY REGION, 2019-2030, MILLION USD
TABLE 45. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
TABLE 46. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
TABLE 47. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
TABLE 48. U.S. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
TABLE 49. U.S. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
TABLE 50. U.S. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
TABLE 51. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
TABLE 52. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
TABLE 53. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
TABLE 54. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
TABLE 55. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
TABLE 56. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
TABLE 57. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
TABLE 58. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
TABLE 59. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
TABLE 60. UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
TABLE 61. UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
TABLE 62. UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
TABLE 63. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
TABLE 64. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
TABLE 65. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
TABLE 66. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
TABLE 67. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
TABLE 68. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
TABLE 69. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
TABLE 70. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
TABLE 71. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
TABLE 72. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
TABLE 73. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
TABLE 74. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
TABLE 75. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
TABLE 76. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
TABLE 77. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
TABLE 78. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
TABLE 79. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
TABLE 80. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
TABLE 81. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
TABLE 82. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
TABLE 83. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
TABLE 84. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
TABLE 85. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
TABLE 86. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
TABLE 87. REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
TABLE 88. REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
TABLE 89. REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
TABLE 90. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
TABLE 91. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
TABLE 92. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
TABLE 93. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
TABLE 94. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
TABLE 95. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
TABLE 96. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
TABLE 97. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
TABLE 98. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
TABLE 99. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
TABLE 100. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
TABLE 101. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
TABLE 102. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
TABLE 103. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
TABLE 104. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
TABLE 105. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
TABLE 106. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
TABLE 107. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
TABLE 108. REST OF ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
TABLE 109. REST OF ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
TABLE 110. REST OF ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
TABLE 111. REST OF WORLD CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
TABLE 112. REST OF WORLD CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
TABLE 113. REST OF WORLD CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
TABLE 114. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
TABLE 115. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
TABLE 116. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
TABLE 117. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
TABLE 118. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
TABLE 119. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
TABLE 120. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
TABLE 121. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
TABLE 122. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
TABLE 123. VENEZUELA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
TABLE 124. VENEZUELA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
TABLE 125. VENEZUELA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
TABLE 126. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
TABLE 127. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
TABLE 128. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
TABLE 129. REMAINING COUNTRIES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
TABLE 130. REMAINING COUNTRIES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
TABLE 131. REMAINING COUNTRIES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
TABLE 132. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 133. ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 134. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 135. ABBOTT LABORATORIES: KEY STRATERGY
TABLE 136. MENARINI DIAGNOSTICS S.R.L.: COMPANY SNAPSHOT
TABLE 137. MENARINI DIAGNOSTICS S.R.L.: OPERATING SEGMENTS
TABLE 138. MENARINI DIAGNOSTICS S.R.L.: PRODUCT PORTFOLIO
TABLE 139. MENARINI DIAGNOSTICS S.R.L.: KEY STRATERGY
TABLE 140. DEXCOM, INC.: COMPANY SNAPSHOT
TABLE 141. DEXCOM, INC.: OPERATING SEGMENTS
TABLE 142. DEXCOM, INC.: PRODUCT PORTFOLIO
TABLE 143. DEXCOM, INC.: KEY STRATERGY
TABLE 144. ECHO THERAPEUTICS, INC.: COMPANY SNAPSHOT
TABLE 145. ECHO THERAPEUTICS, INC.: OPERATING SEGMENTS
TABLE 146. ECHO THERAPEUTICS, INC.: PRODUCT PORTFOLIO
TABLE 147. ECHO THERAPEUTICS, INC.: KEY STRATERGY
TABLE 148. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
TABLE 149. HOFFMANN-LA ROCHE LTD.: OPERATING SEGMENTS
TABLE 150. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
TABLE 151. HOFFMANN-LA ROCHE LTD.: KEY STRATERGY
TABLE 152. GLYSENS INCORPORATED: COMPANY SNAPSHOT
TABLE 153. GLYSENS INCORPORATED: OPERATING SEGMENTS
TABLE 154. GLYSENS INCORPORATED: PRODUCT PORTFOLIO
TABLE 155. GLYSENS INCORPORATED: KEY STRATERGY
TABLE 156. INSULET CORPORATION: COMPANY SNAPSHOT
TABLE 157. INSULET CORPORATION: OPERATING SEGMENTS
TABLE 158. INSULET CORPORATION: PRODUCT PORTFOLIO
TABLE 159. INSULET CORPORATION: KEY STRATERGY
TABLE 160. JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 161. JOHNSON & JOHNSON: OPERATING SEGMENTS
TABLE 162. JOHNSON & JOHNSON: PRODUCT PORTFOLIO
TABLE 163. JOHNSON & JOHNSON: KEY STRATERGY
TABLE 164. MEDRONIC PLC: COMPANY SNAPSHOT
TABLE 165. MEDRONIC PLC: OPERATING SEGMENTS
TABLE 166. MEDRONIC PLC: PRODUCT PORTFOLIO
TABLE 167. MEDRONIC PLC: KEY STRATERGY
TABLE 168. SENSEONICS HOLDINGS, INC.: COMPANY SNAPSHOT
TABLE 169. SENSEONICS HOLDINGS, INC.: OPERATING SEGMENTS
TABLE 170. SENSEONICS HOLDINGS, INC.: PRODUCT PORTFOLIO
TABLE 171. SENSEONICS HOLDINGS, INC.: KEY STRATERGY
LIST OF FIGURES
FIGURE 1. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENTS, 2019-2030, MILLION USD
FIGURE 2. SENSORS MARKET VALUE, BY REGION, 2019-2030, MILLION USD
FIGURE 3. NORTH AMERICA SENSORS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
FIGURE 4. EUROPE SENSORS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
FIGURE 5. ASIA-PACIFIC SENSORS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
FIGURE 6. REST OF WORLD SENSORS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
FIGURE 7. TRANSMITTERS & RECEIVERS MARKET VALUE, BY REGION, 2019-2030, MILLION USD
FIGURE 8. NORTH AMERICA TRANSMITTERS & RECEIVERS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
FIGURE 9. EUROPE TRANSMITTERS & RECEIVERS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
FIGURE 10. ASIA-PACIFIC TRANSMITTERS & RECEIVERS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
FIGURE 11. REST OF WORLD TRANSMITTERS & RECEIVERS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
FIGURE 12. INTEGRATED INSULIN PUMPS MARKET VALUE, BY REGION, 2019-2030, MILLION USD
FIGURE 13. NORTH AMERICA INTEGRATED INSULIN PUMPS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
FIGURE 14. EUROPE INTEGRATED INSULIN PUMPS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
FIGURE 15. ASIA-PACIFIC INTEGRATED INSULIN PUMPS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
FIGURE 16. REST OF WORLD INTEGRATED INSULIN PUMPS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
FIGURE 17. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
FIGURE 18. ADULT POPULATION (>14 YEARS) MARKET VALUE, BY REGION, 2019-2030, MILLION USD
FIGURE 19. NORTH AMERICA ADULT POPULATION (>14 YEARS) MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
FIGURE 20. EUROPE ADULT POPULATION (>14 YEARS) MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
FIGURE 21. ASIA-PACIFIC ADULT POPULATION (>14 YEARS) MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
FIGURE 22. REST OF WORLD ADULT POPULATION (>14 YEARS) MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
FIGURE 23. CHILDREN POPULATION (≤14 YEARS) MARKET VALUE, BY REGION, 2019-2030, MILLION USD
FIGURE 24. NORTH AMERICA CHILDREN POPULATION (≤14 YEARS) MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
FIGURE 25. EUROPE CHILDREN POPULATION (≤14 YEARS) MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
FIGURE 26. ASIA-PACIFIC CHILDREN POPULATION (≤14 YEARS) MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
FIGURE 27. REST OF WORLD CHILDREN POPULATION (≤14 YEARS) MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
FIGURE 28. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
FIGURE 29. DIAGNOSTIC CENTERS/CLINICS MARKET VALUE, BY REGION, 2019-2030, MILLION USD
FIGURE 30. NORTH AMERICA DIAGNOSTIC CENTERS/CLINICS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
FIGURE 31. EUROPE DIAGNOSTIC CENTERS/CLINICS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
FIGURE 32. ASIA-PACIFIC DIAGNOSTIC CENTERS/CLINICS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
FIGURE 33. REST OF WORLD DIAGNOSTIC CENTERS/CLINICS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
FIGURE 34. ICUS MARKET VALUE, BY REGION, 2019-2030, MILLION USD
FIGURE 35. NORTH AMERICA ICUS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
FIGURE 36. EUROPE ICUS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
FIGURE 37. ASIA-PACIFIC ICUS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
FIGURE 38. REST OF WORLD ICUS MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
FIGURE 39. HOME HEALTHCARE MARKET VALUE, BY REGION, 2019-2030, MILLION USD
FIGURE 40. NORTH AMERICA HOME HEALTHCARE MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
FIGURE 41. EUROPE HOME HEALTHCARE MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
FIGURE 42. ASIA-PACIFIC HOME HEALTHCARE MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
FIGURE 43. REST OF WORLD HOME HEALTHCARE MARKET VALUE, BY COUNTRY, 2019-2030, MILLION USD
FIGURE 44. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY REGION, 2019-2030, MILLION USD
FIGURE 45. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
FIGURE 46. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
FIGURE 47. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
FIGURE 48. U.S. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
FIGURE 49. U.S. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
FIGURE 50. U.S. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
FIGURE 51. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
FIGURE 52. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
FIGURE 53. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
FIGURE 54. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
FIGURE 55. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
FIGURE 56. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
FIGURE 57. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
FIGURE 58. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
FIGURE 59. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
FIGURE 60. UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
FIGURE 61. UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
FIGURE 62. UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
FIGURE 63. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
FIGURE 64. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
FIGURE 65. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
FIGURE 66. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
FIGURE 67. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
FIGURE 68. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
FIGURE 69. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
FIGURE 70. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
FIGURE 71. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
FIGURE 72. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
FIGURE 73. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
FIGURE 74. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
FIGURE 75. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
FIGURE 76. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
FIGURE 77. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
FIGURE 78. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
FIGURE 79. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
FIGURE 80. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
FIGURE 81. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
FIGURE 82. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
FIGURE 83. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
FIGURE 84. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
FIGURE 85. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
FIGURE 86. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
FIGURE 87. REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
FIGURE 88. REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
FIGURE 89. REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
FIGURE 90. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
FIGURE 91. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
FIGURE 92. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
FIGURE 93. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
FIGURE 94. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
FIGURE 95. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
FIGURE 96. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
FIGURE 97. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
FIGURE 98. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
FIGURE 99. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
FIGURE 100. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
FIGURE 101. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
FIGURE 102. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
FIGURE 103. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
FIGURE 104. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
FIGURE 105. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
FIGURE 106. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
FIGURE 107. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
FIGURE 108. REST OF ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
FIGURE 109. REST OF ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
FIGURE 110. REST OF ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
FIGURE 111. REST OF WORLD CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
FIGURE 112. REST OF WORLD CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
FIGURE 113. REST OF WORLD CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
FIGURE 114. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
FIGURE 115. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
FIGURE 116. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
FIGURE 117. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
FIGURE 118. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
FIGURE 119. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
FIGURE 120. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
FIGURE 121. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
FIGURE 122. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
FIGURE 123. VENEZUELA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
FIGURE 124. VENEZUELA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
FIGURE 125. VENEZUELA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
FIGURE 126. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
FIGURE 127. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
FIGURE 128. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
FIGURE 129. REMAINING COUNTRIES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY COMPONENT, 2019-2030, MILLION USD
FIGURE 130. REMAINING COUNTRIES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY DEMOGRAPHICS, 2019-2030, MILLION USD
FIGURE 131. REMAINING COUNTRIES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET VALUE, BY END USER, 2019-2030, MILLION USD
FIGURE 132. ABBOTT LABORATORIES: NET SALES,2017-2019
FIGURE 133. MENARINI DIAGNOSTICS S.R.L.: NET SALES,2017-2019
FIGURE 134. DEXCOM, INC.: NET SALES,2017-2019
FIGURE 135. ECHO THERAPEUTICS, INC.: NET SALES,2017-2019
FIGURE 136. HOFFMANN-LA ROCHE LTD.: NET SALES,2017-2019
FIGURE 137. GLYSENS INCORPORATED: NET SALES,2017-2019
FIGURE 138. INSULET CORPORATION: NET SALES,2017-2019
FIGURE 139. JOHNSON & JOHNSON: NET SALES,2017-2019
FIGURE 140. MEDRONIC PLC: NET SALES,2017-2019
FIGURE 141. SENSEONICS HOLDINGS, INC.: NET SALES,2017-2019